We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$184M
AUM Growth
-$5.72M
Cap. Flow
-$594K
Cap. Flow %
-0.32%
Top 10 Hldgs %
49.88%
Holding
105
New
16
Increased
25
Reduced
26
Closed
9

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$1.54M
2
AMD icon
Advanced Micro Devices
AMD
+$1.11M
3
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.08M
4
BOXX icon
Alpha Architect 1-3 Month Box ETF
BOXX
+$773K
5
XNCR icon
Xencor
XNCR
+$712K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.12M
2
ARGX icon
argenx
ARGX
+$1.81M
3
JNJ icon
Johnson & Johnson
JNJ
+$761K
4
VIR icon
Vir Biotechnology
VIR
+$642K
5
PANW icon
Palo Alto Networks
PANW
+$639K

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.49%
2 Healthcare 33.26%
3 Technology 15.1%
4 Communication Services 6.79%
5 Consumer Discretionary 3.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STEW
51
SRH Total Return Fund
STEW
$1.75B
$766K 0.42%
59,000
– –
B
52
Barrick Mining
B
$72.3B
$764K 0.42%
52,500
– –
RTX icon
53
CALL
RTX Corp
RTX
$261B
$720K 0.39%
+10,000
New +$856K
PAAS icon
54
Pan American Silver
PAAS
$20.7B
$652K 0.36%
45,000
– –
NOK icon
55
Nokia
NOK
$59B
$641K 0.35%
171,500
– –
AMZN icon
56
Amazon
AMZN
$2.72T
$636K 0.35%
5,000
– –
MU icon
57
CALL
Micron Technology
MU
$1.1T
$612K 0.33%
9,000
+500
+6% +$33.5K
META icon
58
Meta Platforms (Facebook)
META
$1.71T
$600K 0.33%
2,000
-200
-9% -$60.3K
AAPL icon
59
PUT
Apple
AAPL
$4.87T
$599K 0.33%
+3,500
New +$642K
QCOM icon
60
PUT
Qualcomm
QCOM
$205B
$555K 0.3%
+5,000
New +$580K
WOLF icon
61
Wolfspeed
WOLF
$1.27B
$533K 0.29%
14,000
+7,000
+100% +$366K
SNY icon
62
Sanofi
SNY
$103B
$531K 0.29%
9,900
– –
EVO icon
63
Evotec
EVO
$593M
$484K 0.26%
49,047
+6,309
+15% +$74.1K
EEM icon
64
iShares MSCI Emerging Markets ETF
EEM
$31.1B
$474K 0.26%
12,500
– –
TEVA icon
65
Teva Pharmaceutical Industries Limited
TEVA
$46.1B
$454K 0.25%
44,500
+5,500
+14% +$51.2K
BA icon
66
Boeing
BA
$158B
$383K 0.21%
2,000
-500
-20% -$109K
ALNY icon
67
Alnylam Pharmaceuticals
ALNY
$32.4B
$319K 0.17%
1,800
+200
+13% +$38.2K
MSFT icon
68
PUT
Microsoft
MSFT
$3.7T
$316K 0.17%
+1,000
New +$330K
LRCX icon
69
Lam Research
LRCX
$335B
$313K 0.17%
5,000
– –
ALT icon
70
Altimmune
ALT
$644M
$312K 0.17%
119,975
– –
SPOT icon
71
Spotify
SPOT
$111B
$309K 0.17%
2,000
– –
AMD icon
72
CALL
Advanced Micro Devices
AMD
$873B
$308K 0.17%
+3,000
New +$326K
BMY icon
73
Bristol-Myers Squibb
BMY
$129B
$305K 0.17%
+5,250
New +$322K
RVNC
74
DELISTED
Revance Therapeutics, Inc.
RVNC
$304K 0.17%
+26,500
New +$509K
C icon
75
Citigroup
C
$220B
$298K 0.16%
7,250
– –
1 2
3
4 5

Similar funds

LT
Legacy Trust Grand Rapids, Michigan $566M AUM 34.04% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
B
BetterWealth San Jose, California $565M AUM 23.16% 1-Year Est. Return
PCM
Primavera Capital Management George Town, Cayman Islands $565M AUM 11.43% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $565M AUM 22.27% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $565M AUM 19.78% 1-Year Est. Return
CWA
Clarity Wealth Advisors San Jose, California $567M AUM 27.85% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

DCF Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, DCF Advisers held 105 positions worth $184M, down 3% from $189M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

DCF Advisers's Q3 2023 filing shows 16 new, 25 increased, 26 reduced and 9 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 13,500 shares worth $986K. The largest sale was Amgen, an estimated $2.12M.

By sector, the portfolio is most concentrated in Miscellaneous at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Technology.

  • DCF Advisers's largest Q3 2023 buy was State Street SPDR S&P Biotech ETF: 13,500 shares worth $986K.
  • DCF Advisers added most to iShares Russell 2000 ETF in Q3 2023, an estimated $1.54M increase.
  • DCF Advisers's biggest Q3 2023 reduction was Amgen, cutting an estimated $2.12M.
  • DCF Advisers fully exited Palo Alto Networks in Q3 2023, selling an estimated $639K.
  • DCF Advisers's ten largest holdings make up 50% of its $184M portfolio in Q3 2023.
  • DCF Advisers opened 16 new positions and closed 9 in Q3 2023.
  • DCF Advisers's portfolio value fell 3% quarter-over-quarter to $184M.

Based on DCF Advisers's 13F filing for Q3 2023, filed 13 Nov 2023.